ANNA WILLIAMSON: Open Payments
NPI 1447807805 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$740 in 52 payments from 12 companies in 2025. Trend: 2023 $577 · 2024 $1,064 · 2025 $740
Food & beverage: $740
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $467 |
| Regeneron Healthcare Solutions, Inc. | 2 | $57 |
| Janssen Biotech, Inc. | 3 | $55 |
| Celltrion USA Inc. | 2 | $27 |
| Enterra Medical, Inc. | 1 | $26 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Intercept Pharmaceuticals, Inc. | 1 | $18 |
| Madrigal Pharmaceuticals | 1 | $16 |
| Ardelyx, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
Products named: RINVOQ, CREON, DUPIXENT, TREMFYA, LINZESS, SKYRIZI, BOTOX, VEGZELMA.
Industry payments across MS — which companies pay providers there.
